Search

Home > The Bio Report > Dyadic Seek to Bring Disruptive Technology to Biomanufacturing
Podcast: The Bio Report
Episode:

Dyadic Seek to Bring Disruptive Technology to Biomanufacturing
Category: Business
Duration: 00:22:49
Publish Date: 2017-06-15 11:27:36
Description: The production of biologics is costly and takes time. Dyadic International has developed a proprietary manufacturing process that replaces the use of Chinese hamster ovary cells, long used to produce protein therapeutics, with a fungus that has a long history in industrial biotechnology applications. The company believes its process can produce drugs faster, in greater volumes, and at significantly lower costs than biotech processes in use today. We spoke to Mark Emalfarb, CEO of Dyadic, about its manufacturing process, the benefits it could bring, and why it may have big implications for drugmakers.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes
The Bio Repo ..